Laëtitia Furhmann (Laetitia Fuhrmann)

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 7

Top Topics

Gene Expression

Neoadjuvant Chemotherapy

Top Venues

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Science signaling

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Joanna Cyrta, Camille Benoist, Julien Masliah-Planchon, Andre F Vieira, Gaëlle Pierron, Laëtitia Furhmann, Camille Richardot, Martial Caly, Renaud Leclere, Odette Mariani, Elisabeth Da Maia, Frédérique Larousserie, Jean Guillaume Féron, Matthieu Carton, Victor Renault, Francois-Clement Bidard, Anne-Vincent Salomon
Breast carcinomas with osteoclast-like giant cells: a comprehensive clinico-pathological and molecular portrait and evidence of RANK-L expression. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 35 (11) (2022)
Catalina Lodillinsky, Laëtitia Furhmann, Marie Irondelle, Olena Pylypenko, Xiao-Yan Li, Hélène Bonsang-Kitzis, Fabien Reyal, Sophie Vacher, Claire Calmel, Olivier De Wever, Ivan Bièche, Marie-Lise Lacombe, Ana Maria Eiján, Anne Houdusse, Anne-Vincent Salomon, Stephen J Weiss, Philippe Chavrier, Mathieu Boissan
Metastasis-suppressor NME1 controls the invasive switch of breast cancer by regulating MT1-MMP surface clearance. Oncogene 40 (23) (2021)
Florence Coussy, Rania El-Botty, Sophie Château-Joubert, Ahmed Dahmani, Elodie Montaudon, Sophie Leboucher, Ludivine Morisset, Pierre Painsec, Laura Sourd, Léa Huguet, Fariba Nemati, Jean-Luc Servely, Thibaut Larcher, Sophie Vacher, Adrien Briaux, Cécile Reyes, Philippe La Rosa, Georges Lucotte, Tatiana Popova, Pierre Foidart, Nor Eddine Sounni, Agnès Noel, Didier Decaudin, Laëtitia Furhmann, Anne Salomon, Fabien Reyal, Christopher R Mueller, Petra Ter Brugge, Jos Jonkers, Marie-France Poupon, Marc-Henri Stern, Ivan Bièche, Yves Pommier, Elisabetta Marangoni
BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers. Science translational medicine 12 (531) (2021)
Wei-Wei Shen, Ivan Bièche, Laëtitia Furhmann, Sophie Vacher, Anne Vincent-Salomon, Stephanie Torrino, Christophe Lamaze
EHD2 is a Predictive Biomarker of Chemotherapy Efficacy in Triple Negative Breast Carcinoma. Scientific reports 10 (1) (2020)
Jean-Christophe Tille, André F Vieira, Caroline Saint-Martin, Lounes Djerroudi, Laëtitia Furhmann, Francois-Clement Bidard, Youlia Kirova, Anne Tardivon, Fabien Reyal, Matthieu Carton, Anne Vincent-Salomon
Tumor-infiltrating lymphocytes are associated with poor prognosis in invasive lobular breast carcinoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 33 (11) (2020)
Floriane Pelon, Brigitte Bourachot, Yann Kieffer, Ilaria Magagna, Fanny Mermet-Meillon, Isabelle Bonnet, Ana Costa, Anne-Marie Givel, Youmna Atieh, Jorge Barbazan, Claire Bonneau, Laëtitia Furhmann, Stephanie Descroix, Danijela Matic Vignjevic, Pascal Silberzan, Maria Carla Parrini, Anne Vincent-Salomon, Fatima Mechta-Grigoriou
Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms. Nature communications 11 (1) (2020)
Clémence Thomas, Whitney Henry, Benjamin G Cuiffo, Anthony Y Collmann, Elisabetta Marangoni, Vanessa Benhamo, Manoj K Bhasin, Cheng Fan, Laëtitia Furhmann, Albert S Baldwin, Charles M Perou, Anne Vincent-Salomon, Alex Toker, Antoine E Karnoub
Pentraxin-3 is a PI3K signaling target that promotes stem cell-like traits in basal-like breast cancers. Science signaling 10 (467) (2017)